Genomics Market Size to be Worth US$ 62,614.6 Mn by 2026

Genomics Industry 2019 Fortune Business Insights report presents you analysis of market size, share, and growth, trends, and cost structure, statistical and comprehensive data of the global market forecast till 2026

Pune, India - July 19, 2019 /MarketersMedia/ —

The use of genomics is expanding in the medical industry, which is creating growth opportunities for the global genomics market. Fortune Business Insights in a new report, titled “Genomics: Global Market Analysis, Insights and Forecast, 2019-2026” offers valuable insights into the factors enabling growth in the market.

Browse Complete Report Details @
https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Genomics is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, the global market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026.

In 2018, the market was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026. The gradual shift from traditional medicine to precision medicine is positively changing the healthcare environment. Genomics plays a crucial role in the treatment and diagnosis of chronic diseases.

Some of the Main Key Players Covered in the Report

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Hoffmann-La Roche Ltd
• Agilent Technologies, Inc.
• Oxford Nanopore Technologies
• Danaher
• QIAGEN
• BGI
• IntegraGen
• General Electric Company

Adoption of Advanced Technologies Renders North America Dominant

From a geographical standpoint, North America dominated the global genomics market in 2018. The region will continue to maintain its dominance through the forecast period. Rapid technological advancements and the presence of sophisticated healthcare infrastructure are driving the market in this region.

In 2018, North America was valued at US$ 6,959.3 Mn. The demand for genomic medicine is increasing in North America on account of the rising adoption of personalized medicine and new sequencing technologies.

Europe is expected to display great growth potential owing to the wide availability of funds and the presence of large MNCs. Governments in the U.K. is increasingly making investments in research and development (R&D) activities to favour the expansion of the market in Europe.

The market in Asia Pacific is likely to witness strong growth during the forecast years. The primary factor responsible for the growth is developing healthcare infrastructure. The awareness about genomic technologies is increasing in countries such as India and China, as people in these countries are becoming more aware with regards to the detection of genetic disorders, their treatment and prognosis. All these factors are enabling growth in the market.

Get Sample PDF Brochure@
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

A Myriad of R&D Activities Has Spurred Growth Prospects for Genomics Market

“Several services and start-up companies are paving their way into genomics industry by offering services which include ancestry services, direct-to-customer genomic services, among others,” stated a lead analyst at Fortune Business Insights. “Rising support from governments regarding research and funding is expected to contribute to the growth of the market,” he added.

Several genomic institutes are supporting the industry by granting funds for performing research and development activities. Stanford healthcare uses genomic information to develop a personalized treatment for patients suffering from chronic illness.The lower costs of genetic procedures is likely to contribute to the development of the genomic market in the forthcoming years. Technological advancements in genomic medicine which include Next-generation Sequencing (NGS), Sanger sequencing, Polymerase Chain Reactions (PCR), and microarray are likely to drive the market.

Of these, Polymerase Chain Reactions (PCR) covered the maximum share in the global market in 2018. The easy availability and extensive use of this technology are responsible for this segment’s growth. Owing to the increasing number of genetic studies, the demand for genomics is expected to fuel in healthcare facilities & diagnostic centers, Contract Research Organization (CROs) and others.

Veritas Genetics Launched myGenome to Offer Personalized Services to its Customers

General Electric Company, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies, Agilent Technologies, Inc., IntegraGen, QIAGEN, BGI, F. Hoffmann-La Roche Ltd, Danaher, and Illumina, Inc. are some of the leading players in the global genomics market. Among these, F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., and Illumina, Inc. are projected to dominate the global market. Strong geographical presence and robust portfolio are factors responsible for their prominent position in the market. Several companies are entering into strategic alliances to better their market position and increase revenue.

Bristol Myers Squibb collaborated with Foundation Medicine in March 2017. This collaboration will help the former company to leverage the latter’s molecular information and genomic profiling solutions. Furthermore, it will help Bristol Myers to identify biomarkers such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB) in cancer patients. Another company called 10X Genomics acquired an epigenomics-based startup called Epinomics in August 2018. This acquisition will help the company strengthen its market position.

TOC followed by:

1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2.Executive Summary
3.Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4 Market Trends
4.Key Insights
4.1GenomicsResearch Spending - For Key Countries, 2018
4.2RegulatoryScenario - For Key Countries
4.3Overview of Genomics Service Provider
4.4New Product Launch
4.5Start-upswith their Funding Overview
4.5Key Industry Developments - Mergers, Acquisitions and Partnerships
5.Global Genomics Market Analysis, Insights and Forecast, 2015-2026
5.1.Key Findings / Summary
5.2.Market Analysis, Insights and Forecast – By Type
5.2.1Product
5.2.1.1Instruments& Software
5.2.1.2Consumables
5.2.2Services

More Trending Topics from Future Business Insights:

Hemostatic Agents Market to reach US$ 5,441.5 Mn by 2025, at a CAGR of 6.4% | Exclusive Report by Fortune Business Insights

Global Commercial Seed Market to Value US$ 61.32 Bn by 2025, Increasing Subsidies Provided to Farmers will Boost Market, says Fortune Business Insights

Cardiovascular Stents Market to Exhibit 6.6% CAGR, Development of Bioresorbable Stents to Boost Market, Says Fortune Business Insights

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Mr. Ashwin Arora
Email: Send Email
Organization: Fortune Business Insights Pvt. Ltd
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/genomics-market-size-to-be-worth-us-626146-mn-by-2026/88899084

Source: MarketersMedia

Release ID: 88899084

Other News

Streep, Miranda and Stone are named as Met Gala co-0chairs

Dec 10, 2019

NEW YORK — Next year's Met Gala may be the closest we'll ever come to getting a Miranda Priestly moment at the starry event. Meryl Streep has been named as a co-chair of the Metropolitan Museum of Art's Costume Institute. The Oscar-winner played Priestly, a thinly veiled fictional version of Vogue editor Anna Wintour, in the movie "The Devil Wears Prada." Wintour clearly has no hard feelings because she selected Streep as a co-chair along with Lin-Manuel Miranda and fellow Oscar-winner Emma Stone. Designer Nicolas Ghesquiere rounds out the group. The gala's theme is "About Time: Fashion and Duration," which...

Iconic Puerto Rican astrologer Walter Mercado dies at 88

Dec 10, 2019

SAN JUAN, Puerto Rico — Television astrologer Walter Mercado, whose flamboyant persona made him a star in Latin media and a cherished icon for gay people in most of the Spanish-speaking world, has died. He was 88. Mercado was known throughout Latin American for the melodrama of his daily horoscopes, delivered on internationally broadcast networks such as Univision with an exaggerated trilling of the "r''. He favored colorful brocaded capes and huge gemstone rings, which he flashed while pointing at viewers. Mercado never publicly discussed his sexual orientation but his screen presence was a source of comfort for many people...

Olivia Newton-John's final 'Grease' ensemble fetches $405K

Dec 10, 2019

BEVERLY HILLS, Calif. — Two collectors said you're the one that I want to Olivia Newton-John's iconic "Grease" leather jacket and skintight pants at an auction Saturday in Beverly Hills. Julien's Auctions says the combined ensemble, which Newton-John's character Sandy wears in the closing number of the 1978 film, fetched $405,700 total. The leather jacket sold for $243,200 and the pants, which Newton-John famously had to be sewn into, went for $162,500. Other "Grease" memorabilia included a Pink Ladies jacket that went for $50,000 and a poster signed by Newton-John, John Travolta, director Randal Kleiser and producer and songwriter John...

Scorsese, De Niro and Pacino on time and 'The Irishman'

Dec 10, 2019

NEW YORK — They come into the room not like the moveable Mount Rushmore that they are but like three old friends, energized by being in each other's company. They are chatting about movies. Martin Scorsese comes first, then Al Pacino, then Robert De Niro. They're trailed by a small army of publicists and assistants that quickly recedes out of the room. Constant through the momentary commotion is Scorsese enthusiastically remembering Michael Powell and Emeric Pressburger's "A Matter of Life and Death," and quoting its lines to a rapt Pacino. Their movie, "The Irishman," also deals majestically with matters of...

After son's death, Craig Morgan finds God's purpose in song

Dec 10, 2019

NASHVILLE, Tenn. — The last evening that country singer Craig Morgan spent with his 19-year-old son, Jerry, was during one of Morgan's performances at Grand Ole Opry three years ago. "The last pictures I have of us together is on that stage," Morgan, 55, said backstage at the Opry House this week. "So this is a very special place. It was anyway before, but now it has additional meaning, knowing this is where we hung out together." His son, Jerry, who was home visiting from college, died in a drowning accident on Kentucky Lake in July 2016. Three years later,...

Enter Wicked dives into the Entertainment World seeking to report the hot topics going on with celebrities.

Contact us: sales@enterwicked.com